GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Thermo Fisher Scientific’s new refrigerators poised to make profound impact on medical devices market, says GlobalData

Thermo Fisher Scientific recently unveiled a ground-breaking addition to its product portfolio – the Thermo Scientific TSG Series Refrigerators. These innovative refrigerators are specifically designed to address the vital need for secure storage of critical vaccines and pharmaceuticals within laboratory, pharmacy, and clinical settings. The impact of this innovation on the medical devices market is […]
Read more

National Immunization Awareness Month provides opportunities to increase influenza vaccination rates, says GlobalData

August is observed as National Immunization Awareness Month (NIAM) in the US to highlight the importance of vaccines in preventing serious illness, complications, and death from infectious diseases. The intention is to educate individuals on the importance of staying up-to-date with routine vaccinations*. During the 2022-2023 influenza season, vaccination was responsible for averting 36.25% of […]
Read more

GlobalData report highlights staggering economic costs for Indiana of $9.3 billion due to obesity

Obesity and overweight are estimated to have caused a staggering $9.3 billion reduction in Indiana’s economy in 2022, equivalent to 2% of the state’s gross domestic product, according to a report released by GlobalData Plc, a leading data and analytics company. GlobalData’s report, ‘Obesity’s Impact on Indiana’s Economy and Labor Force,’ analyzes the economic and […]
Read more

US will continue to lead global LNG liquefaction capacity additions through 2027, says GlobalData

The US is set to continue to lead global liquefied natural gas (LNG) liquefaction capacity additions, contributing 46% of the total LNG liquefaction capacity additions between 2023 and 2027, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “LNG Liquefaction Terminals Capacity and Capital Expenditure (CapEx) Forecast by Region, Key Countries, Companies […]
Read more

More pricing pain for pharma as new legislation expands scope of Inflation Reduction Act, says GlobalData

The global pharma industry is bracing itself for more headaches in its most profitable market as US House Democratic health leaders introduce new legislation, which would expand the Inflation Reduction Act and further lower prescription drug prices. House Democrats Frank Pallone Jr., Richard Neal, and Robert Scott unveiled the Lowering Drug Costs for American Families […]
Read more

Oil and gas industry overall contract value up by 60% QoQ during Q2 2023, reveals GlobalData

The overall oil and gas industry’s disclosed contract value witnessed a significant quarter-on-quarter (QoQ) increase of 60% in Q2 2023, mainly driven by a mega contract for Qatar’s North Field South (NFS) LNG project, reveals GlobalData, a leading data and analytics company. GlobalData’s latest report, “Oil and Gas Industry Contracts Analytics by Sector (Upstream, Midstream […]
Read more

Lotte looks to tap Indian festive demand with Coffy Bite Rich candy launch, says GlobalData

Confectionery manufacturers are gearing up to launch new products for the upcoming Indian festival season, incentivized by the low inflationary pressure on the category. Sales of hard-boiled sweets, one of the largest segments of sugar confectionery, are rising due to their pocket-friendly pricing and diverse consumption occasions. Leading confectionery manufacturers, such as Lotte with its […]
Read more

NASH market holds enormous untapped potential, says GlobalData

The prevalence of nonalcoholic steatohepatitis (NASH), a more advanced stage of nonalcoholic fatty liver disease (NAFLD), continues to increase. Following the receipt of a complete response letter (CRL) from the FDA for its farnesoid X receptor (FXR) agonist, obeticholic acid (OCA), in NASH, Intercept Pharmaceuticals has joined the list of companies who have failed to […]
Read more

China chemiluminescence analyzers market to reach $45 million by 2033, forecasts GlobalData

Owing to the growing number of cases with infectious and cardiovascular diseases, chemiluminescence analyzers are gaining interest in China due to their high sensitivity and specificity. Against this backdrop, China’s chemiluminescence analyzers market is anticipated to reach $45 million in 2033, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, ‘Immunochemistry Analyzers Market Size […]
Read more

Asia to lead global purified terephthalic acid capacity additions by 2027, says GlobalData

Asia is set to lead the global purified terephthalic acid (PTA) industry capacity additions with a share of 89% by 2027, by gaining capacities from new-build and expansion projects between 2023 and 2027, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Purified Terephthalic Acid (PTA) Industry Installed Capacity and Capital Expenditure […]
Read more

Zynlonta’s clinical failure will increase opportunities for competing ADCs in DLBCL, says GlobalData

ADC Therapeutics recently announced plans to discontinue the Phase II LOTIS-9 trial investigating the combination of Zynlonta and rituximab in unfit or frail previously untreated diffuse large B-cell lymphoma (DLBCL) patients following reports of excessive respiratory-related treatment-emergent adverse events. The company disclosed that it will cease its investigation of the Zynlonta-rituximab regimen in this patient […]
Read more
1 104 105 106 107 108 136